| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Schizophrenia | Phase 1 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 2/Phase 3 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 3 | ClinicalTrials |
| Hepatic Insufficiency; Liver Failure | Phase 1 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 3 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 2 | ClinicalTrials |
| Schizophrenia | Phase 3 | ClinicalTrials |
CONTENTS